Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $55.9B |
| FY2017, ended Dec 31, 2017 | $73.5B |
| FY2018, ended Dec 31, 2018 | $83.1B |
| FY2019, ended Dec 31, 2019 | $118B |
| FY2020, ended Dec 31, 2020 | $151B |
| FY2021, ended Dec 31, 2021 | $183B |
| FY2022, ended Dec 31, 2022 | $166B |
| FY2023, ended Dec 31, 2023 | $125B |
| FY2024, ended Dec 31, 2024 | $147B |
| FY2025, ended Dec 31, 2025 | $167B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $194B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.1B |
| FY2017, ended Dec 31, 2017 | $17.2B |
| FY2018, ended Dec 31, 2018 | $16.7B |
| FY2019, ended Dec 31, 2019 | $19.2B |
| FY2020, ended Dec 31, 2020 | $18.0B |
| FY2021, ended Dec 31, 2021 | $18.8B |
| FY2022, ended Dec 31, 2022 | $23.0B |
| FY2023, ended Dec 31, 2023 | $28.1B |
| FY2024, ended Dec 31, 2024 | $24.8B |
| FY2025, ended Dec 31, 2025 | $27.4B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $27.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.91B |
| FY2017, ended Dec 31, 2017 | $5.38B |
| FY2018, ended Dec 31, 2018 | $6.64B |
| FY2019, ended Dec 31, 2019 | $3.77B |
| FY2020, ended Dec 31, 2020 | $2.92B |
| FY2021, ended Dec 31, 2021 | $3.57B |
| FY2022, ended Dec 31, 2022 | $4.15B |
| FY2023, ended Dec 31, 2023 | $7.31B |
| FY2024, ended Dec 31, 2024 | $6.95B |
| FY2025, ended Dec 31, 2025 | $6.83B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $8.18B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.29B |
| FY2017, ended Dec 31, 2017 | $1.71B |
| FY2018, ended Dec 31, 2018 | $638M |
| FY2019, ended Dec 31, 2019 | $600M |
| FY2020, ended Dec 31, 2020 | $1.10B |
| FY2021, ended Dec 31, 2021 | $639M |
| FY2022, ended Dec 31, 2022 | $1.60B |
| FY2023, ended Dec 31, 2023 | $2.69B |
| FY2024, ended Dec 31, 2024 | $1.49B |
| FY2025, ended Dec 31, 2025 | $2.81B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $2.00B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.8B |
| FY2017, ended Dec 31, 2017 | $35.0B |
| FY2018, ended Dec 31, 2018 | $37.7B |
| FY2019, ended Dec 31, 2019 | $42.6B |
| FY2020, ended Dec 31, 2020 | $47.6B |
| FY2021, ended Dec 31, 2021 | $54.1B |
| FY2022, ended Dec 31, 2022 | $63.6B |
| FY2023, ended Dec 31, 2023 | $73.0B |
| FY2024, ended Dec 31, 2024 | $82.1B |
| FY2025, ended Dec 31, 2025 | $95.0B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $103B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 11.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.87B |
| FY2017, ended Dec 31, 2017 | 1.88B |
| FY2018, ended Dec 31, 2018 | 1.91B |
| FY2019, ended Dec 31, 2019 | 1.96B |
| FY2020, ended Dec 31, 2020 | 1.96B |
| FY2021, ended Dec 31, 2021 | 1.96B |
| FY2022, ended Dec 31, 2022 | 1.99B |
| FY2023, ended Dec 31, 2023 | 2.05B |
| FY2024, ended Dec 31, 2024 | 2.06B |
| FY2025, ended Dec 31, 2025 | 2.08B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 2.09B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Sold for cash |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $77.0M | $537M |
| FY2017, ended Dec 31, 2017 | $76.0M | $55.0M |
| FY2018, ended Dec 31, 2018 | $82.0M | $718M |
| FY2019, ended Dec 31, 2019 | $100M | $1.49B |
| FY2020, ended Dec 31, 2020 | $107M | — |
| FY2021, ended Dec 31, 2021 | $119M | $14.0M |
| FY2022, ended Dec 31, 2022 | $142M | $1.51B |
| FY2023, ended Dec 31, 2023 | $139M | $4.51B |
| FY2024, ended Dec 31, 2024 | $138M | $48.0M |
| FY2025, ended Dec 31, 2025 | $185M | $2.04B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — | $2.05B |
Valuation
At current price- Market Cap
- $172B
- P/E
- 21.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.2×
- Price / Book
- 3.1×
- EV / EBITDA
- 18.1×
Growth
Trailing 12 months- Revenue (TTM)
- $27.9B
- Revenue Growth YoY
- 10.3%
- Revenue CAGR 3Y
- 6.0%
- Revenue CAGR 5Y
- 8.8%
- EPS Growth YoY
- 47.6%
- Net Income Growth YoY
- 48.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 29.5%
- Net Margin
- 29.4%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 15.6%
Earnings
Trailing 12 months- Net Income
- $8.18B
- EPS (diluted)
- $3.94
- EBITDA
- $15.1B
- Operating Income
- $8.23B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $2.00B
- Total Debt
- $103B
- Net Debt
- $101B
- Total Assets
- $221B
- Total Liabilities
- $155B
- Shareholders' Equity
- $55.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.3B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 3.0%
- Dividend / Share
- $2.44
- Beta (5Y)
- 0.65
Every ratio is calculated from the company’s reported figures.